Putative uncharacterized protein ORFG in retron EC67 Antibody

What is the putative uncharacterized protein ORFG in retron EC67?

The putative uncharacterized protein ORFG is a component of retron EC67, a bacterial genetic retroelement found in Escherichia coli. Retrons are bacterial genetic elements that encode reverse transcriptase capable of producing multicopy single-stranded DNA (msDNA) and function as antiphage defense systems . The ORFG protein (Uniprot No. P21321) is part of this defense system, though its exact function within the retron is still being characterized . Retrons like EC67 work by sensing phage infection and activating effector proteins to counter the infection, representing an important component of bacterial immunity against viruses .

What are the basic properties of the antibody against ORFG in retron EC67?

The commercially available antibody against the putative uncharacterized protein ORFG in retron EC67 is a polyclonal antibody raised in rabbits against a recombinant form of the protein expressed in Escherichia coli . It has the following characteristics:

This antibody is designed for research applications, specifically for the detection and study of the ORFG protein in retron EC67 .

How does the retron EC67 system function in bacterial immunity?

Retron EC67 functions as part of bacterial antiphage defense systems. The defense mechanism works through sensing phage infection and activating effector proteins . For retron EC67 specifically, research has shown that it recognizes and responds to phage infection through genetic determinants such as DenB and protein A1, which are involved in DNA degradation during phage infection .

While the exact mechanism of defense varies between different retrons, they generally produce multicopy single-stranded DNA (msDNA) through reverse transcription, which plays a role in the defense process . When a phage infects a bacterium carrying retron EC67, the retron detects specific phage components and initiates a defense response to inhibit phage replication, leading to abortive infection or other protective mechanisms .

How do phages evade the retron EC67 defense system?

Recent research has identified specific mechanisms that phages use to evade retron-based immunity, including retron EC67. One key mechanism is through a protein called Rad (retron anti-defense), encoded by ORF75 in phage ΦSP15 . This protein specifically inhibits retron function by degrading the noncoding RNA (ncRNA) that serves as the precursor for msDNA production .

Experimental evidence shows that Rad reduces both msDNA and ncRNA levels of retrons without affecting the transcript of reverse transcriptase (RT) or effector proteins . The insertion of Rad into phage genomes that are normally susceptible to retron defense can improve their infectivity against bacteria carrying retron EC67 .

Additionally, phages can develop mutations in specific genes to escape retron-mediated immunity. For retron EC67, escaper phage mutants have been found to carry mutations in genes encoding for proteins involved in DNA degradation, such as DenB in T2 phage and protein A1 in T5n/ΦSP15m phages . These findings suggest that retron EC67 may be activated by sensing these phage components during infection.

What is the relationship between retron EC67 and other characterized retrons?

Retron EC67 shares functional similarities with other retrons like EC78 and EC83, all serving as bacterial defense systems against phages, but with distinct sensing mechanisms and effector functions . Unlike retron EC78, which employs PtuAB effector proteins that specifically target tRNA^Tyr, the exact molecular target of retron EC67's effector proteins is still under investigation .

Research on phage escape mechanisms has revealed that while certain anti-defense elements like Rad can protect phages against multiple retrons including EC67, EC78, and EC83, other elements show specificity . For example, tRNA^Tyr can rescue phages specifically from retron EC78 but not EC67, indicating mechanistic differences between these systems .

The comparative analysis of different retrons provides valuable insights into the diversity of bacterial defense strategies and corresponding phage counter-mechanisms. T-even phages show varying susceptibility to retron EC67, with T2 being strongly inhibited while T4 and T6 show only moderate inhibition, suggesting the existence of different retron blockers across phage families .

What experimental approaches can be used to investigate the interaction between retron EC67 and phage anti-defense mechanisms?

These approaches can be used synergistically to understand the molecular mechanisms of retron EC67 function and phage evasion strategies. For instance, researchers have successfully used genome insertions of Rad to improve T7 infectivity against bacteria carrying retron EC67, demonstrating the potential for experimental manipulation of these systems .

What are the optimal protocols for using the anti-ORFG antibody in experimental applications?

When using the anti-ORFG antibody for research applications, several methodological considerations should be taken into account:

For Western Blotting (WB):

• Sample preparation: Prepare protein extracts from E. coli containing retron EC67 using standard lysis buffers (e.g., RIPA buffer with protease inhibitors).

• Protein separation: Use SDS-PAGE with appropriate percentage gels based on the expected molecular weight of ORFG.

• Transfer: Transfer proteins to PVDF or nitrocellulose membranes using standard transfer buffers.

• Blocking: Block membranes with 5% non-fat dry milk or BSA in TBST for 1 hour at room temperature.

• Primary antibody incubation: Dilute the anti-ORFG antibody (CSB-PA324169XA01ENL) at 1:500 to 1:2000 in blocking solution and incubate overnight at 4°C.

• Washing: Wash membranes 3-5 times with TBST.

• Secondary antibody: Incubate with appropriate HRP-conjugated anti-rabbit secondary antibody.

• Detection: Use enhanced chemiluminescence (ECL) reagents for detection.

For ELISA:

• Coating: Coat ELISA plates with recombinant ORFG protein (0.1-1 μg/well) in carbonate buffer overnight at a specific temperature.

• Blocking: Block with 1-5% BSA in PBS for 1-2 hours at room temperature.

• Primary antibody: Add diluted anti-ORFG antibody (1:1000 to 1:5000) and incubate for 1-2 hours.

• Washing: Wash 3-5 times with PBST.

• Secondary antibody: Add HRP-conjugated anti-rabbit antibody and incubate for 1 hour.

• Detection: Add TMB substrate and measure absorbance at 450 nm after stopping the reaction.

Note that optimal dilutions and conditions should be determined empirically for each experimental setup, as they may vary depending on the specific application and sample characteristics .

How can researchers verify the specificity of the anti-ORFG antibody?

Verifying antibody specificity is crucial for reliable experimental results. For the anti-ORFG antibody, the following approaches are recommended:

• Positive and negative controls:

  • Positive control: Use purified recombinant ORFG protein or lysates from E. coli known to express retron EC67.

  • Negative control: Use lysates from E. coli strains lacking retron EC67 or with the ORFG gene knocked out.

• Peptide competition assay: Pre-incubate the antibody with excess recombinant ORFG protein before application to the sample. Specific signal should be significantly reduced or eliminated.

• Immunoprecipitation followed by mass spectrometry: Use the antibody to pull down proteins from bacterial lysates, then identify the captured proteins by mass spectrometry to confirm that ORFG is among the precipitated proteins.

• Cross-reactivity testing: Test the antibody against lysates from bacteria expressing similar but distinct retrons (like EC78 or EC83) to assess potential cross-reactivity with related proteins.

• Genetic validation: Use CRISPR-Cas or other genetic modification techniques to create ORFG-knockout strains and confirm loss of antibody signal.

These validation approaches help ensure that experimental results accurately reflect the presence and behavior of the ORFG protein rather than non-specific interactions or artifacts .

What experimental designs are optimal for investigating retron EC67 function and phage interactions?

When studying retron EC67 function and its interactions with phages, several experimental designs have proven effective:

• Phage escape mutant screening:

  • Infect bacteria containing retron EC67 with phages at high MOI (multiplicity of infection).

  • Collect and isolate phages that successfully infect despite the presence of retron EC67.

  • Sequence these "escaper" phages to identify mutations that enable evasion of retron defense.

  • This approach has successfully identified genetic determinants in phages T5n, ΦSP15m, and T2 that trigger retron EC67 defense .

• Reverse genetic approaches:

  • Introduce suspected trigger genes from phages into expression vectors.

  • Express these genes in bacteria containing retron EC67.

  • Monitor bacterial growth and survival to determine if these genes activate retron defense.

  • This approach can identify specific phage components recognized by retron EC67 .

• Functional validation using phage complementation:

  • Introduce anti-defense genes (like Rad) into phages that are normally susceptible to retron EC67.

  • Assess whether these modified phages can now successfully infect bacteria with retron EC67.

  • This approach has confirmed that exogenous expression of Rad improves T7 infectivity against bacteria carrying retron EC67 .

• Molecular mechanism studies:

  • Use RNA hybridization assays to measure levels of retron components (ncRNA, msDNA) during phage infection.

  • Compare wild-type phages versus those expressing anti-defense proteins like Rad.

  • This approach has revealed that Rad reduces msDNA and ncRNA levels without affecting RT transcripts, indicating a specific mechanism of action .

These experimental designs, used individually or in combination, provide complementary insights into retron EC67 function and phage counter-defense mechanisms.

What are the unexplored aspects of retron EC67 function and structure?

Several aspects of retron EC67 remain incompletely understood and represent important areas for future research:

• Structural biology of ORFG protein: Despite its role in bacterial immunity, the three-dimensional structure of ORFG remains uncharacterized. Structural studies using X-ray crystallography or cryo-electron microscopy could provide insights into its function and mechanism of action.

• Interaction partners: The protein-protein and protein-nucleic acid interactions of ORFG within the retron complex and during phage infection remain largely unexplored. Techniques such as BioID, proximity labeling, or co-immunoprecipitation using the anti-ORFG antibody could help identify these interactions.

• Signaling cascades: The signaling events between phage detection and activation of retron EC67 defense are not fully mapped. How the recognition of phage components like DenB or protein A1 leads to retron activation remains to be elucidated .

• Evolutionary relationships: While related to other retrons like EC78 and EC83, the evolutionary history and divergence of EC67 warrant further investigation to understand how these systems have co-evolved with phage counter-defense mechanisms .

• Regulatory mechanisms: How bacteria regulate the expression and activity of retron EC67 under different conditions, including during phage infection, remains poorly understood and represents an important area for future research.

How might retron research contribute to biotechnological applications?

Research on retron EC67 and related systems has several potential biotechnological applications:

• Phage resistance engineering: Understanding retron-based immunity could allow for the engineering of bacteria with enhanced resistance to specific phages, which could be valuable in industrial fermentation and other biotechnological processes where phage contamination is problematic.

• Antimicrobial development: Insights into bacterial defense mechanisms and phage counter-strategies could inform the development of new antimicrobial approaches that either mimic or circumvent these systems.

• Genetic tools: Retron-derived systems could potentially be developed into genetic tools for bacterial genome engineering, similar to how CRISPR-Cas systems were adapted from bacterial defense systems into powerful genome editing tools.

• Diagnostic applications: Antibodies against retron components, including the anti-ORFG antibody, could be utilized in diagnostic tests to identify and characterize specific bacterial strains or phages.

• Synthetic biology applications: The modular nature of retron systems and their ability to produce specific DNA sequences (msDNA) could be harnessed for synthetic biology applications, potentially allowing for programmable DNA production within bacterial cells.

The continued study of retron EC67, facilitated by tools like the anti-ORFG antibody, will be crucial for realizing these potential applications.